A Novel Educational Control Group Mobile App for Meditation Interventions: Single-Group Feasibility Trial

Jennifer Huberty, Ryan Eckert, Megan Puzia, Breanne Laird, Linda Larkey, Ruben Mesa, Jennifer Huberty, Ryan Eckert, Megan Puzia, Breanne Laird, Linda Larkey, Ruben Mesa

Abstract

Background: Smartphone ownership is becoming ubiquitous among US adults, making the delivery of health interventions via a mobile app (ie, mobile health [mHealth]) attractive to many researchers and clinicians. Meditation interventions have become popular and have been delivered to study participants via mobile apps to improve a range of health outcomes in both healthy adults and those with chronic diseases. However, these meditation mHealth interventions have been limited by a lack of high-quality control groups. More specifically, these studies have lacked consistency in their use of active, time-matched, and attention-matched control groups.

Objective: The purpose of this study is to beta test a novel health education podcast control condition delivered via a smartphone app that would be a strong comparator to be used in future studies of app-based meditation interventions.

Methods: Patients with myeloproliferative neoplasm (MPN) cancer were recruited nationally. Upon enrollment, participants were informed to download the investigator-developed health education podcast app onto their mobile phone and listen to ~60 min/week of cancer-related educational podcasts for 12 weeks. The benchmarks for feasibility included ≥70% of participants completing ≥70% of the prescribed 60 min/week of podcasts, ≥70% of participants reporting that they were satisfied with the intervention, and ≥70% of participants reporting that they enjoyed the health education podcasts.

Results: A total of 96 patients with MPN were enrolled in the study; however, 19 never began the intervention. Of the 77 patients who participated in the intervention, 39 completed the entire study (ie, sustained participation through the follow-up period). Participation averaged 103.2 (SD 29.5) min/week. For 83.3% (10/12) of the weeks, at least 70% of participants completed at least 70% of their total prescribed use. Almost half of participants reported that they enjoyed the health education podcasts (19/39, 48.7%) and were satisfied with the intervention (17/39, 43.6%). There were no significant changes in cancer-related outcomes from baseline to postintervention.

Conclusions: A 12-week, health education podcast mobile app was demanded but not accepted in a sample of patients with cancer. Using the mobile app was not associated with significant changes in cancer-related symptoms. Based on findings from this study, a health education podcast mobile app may be a feasible option as a time- and attention-matched control group for efficacy trials with more extensive formative research for the content of the podcasts and its acceptability by the specific population.

Trial registration: ClinicalTrials.gov NCT03907774; https://ichgcp.net/clinical-trials-registry/NCT03907774.

Keywords: beta test; cancer; digital health; feasibility; mHealth; smartphone.

Conflict of interest statement

Conflicts of Interest: JH and LL both report being members of the Scientific Advisory Board for Calm and serve in paid consulting roles. Neither earn additional financial compensation from the sale of the app. The remaining authors report no conflicts of interest.

©Jennifer Huberty, Ryan Eckert, Megan Puzia, Breanne Laird, Linda Larkey, Ruben Mesa. Originally published in JMIR Formative Research (http://formative.jmir.org), 21.07.2020.

Figures

Figure 1
Figure 1
Mindful Health Lab (MHL) podcast app screenshot.
Figure 2
Figure 2
Study consort diagram. MPN: myeloproliferative neoplasm.
Figure 3
Figure 3
Participation and attrition by week during the intervention period.
Figure 4
Figure 4
Average minutes using podcast app by week.
Figure 5
Figure 5
Average podcast sessions completed by week.
Figure 6
Figure 6
Percent adherence to prescribed podcast app use by week.

References

    1. Mobile fact sheet. Pew Research Center. 2019. [2019-12-31].
    1. mHealth: New horizons of health through mobile technology. World Health Organization. 2011. [2018-12-31].
    1. Robbins R, Krebs P, Jagannathan R, Jean-Louis G, Duncan DT. Health app use among US mobile phone users: analysis of trends by chronic disease status. JMIR Mhealth Uhealth. 2017 Dec 19;5(12):e197. doi: 10.2196/mhealth.7832.
    1. Dorsey ER, Yvonne Chan YF, McConnell MV, Shaw SY, Trister AD, Friend SH. The use of smartphones for health research. Acad Med. 2017 Feb;92(2):157–160. doi: 10.1097/ACM.0000000000001205.
    1. Kinser PA, Robins JL. Control group design: enhancing rigor in research of mind-body therapies for depression. Evid Based Complement Alternat Med. 2013;2013:140467. doi: 10.1155/2013/140467.
    1. Hart T, Fann JR, Novack TA. The dilemma of the control condition in experience-based cognitive and behavioural treatment research. Neuropsychol Rehabil. 2008 Jan;18(1):1–21. doi: 10.1080/09602010601082359.
    1. Duraimani SL. A cross-sectional and longitudinal study of the effects of a mindfulness meditation mobile application platform on reducing stress and anxiety. Int J Yoga. 2019;12(3):226–232. doi: 10.4103/ijoy.IJOY_56_18.
    1. Flett JAM, Hayne H, Riordan BC, Thompson LM, Conner TS. Mobile mindfulness meditation: a randomised controlled trial of the effect of two popular apps on mental health. Mindfulness. 2018 Oct 31;10(5):863–876. doi: 10.1007/s12671-018-1050-9.
    1. Romeo A, Edney S, Plotnikoff R, Curtis R, Ryan J, Sanders I, Crozier A, Maher C. Can smartphone apps increase physical activity? systematic review and meta-analysis. J Med Internet Res. 2019 Mar 19;21(3):e12053. doi: 10.2196/12053.
    1. Freedland KE, King AC, Ambrosius WT, Mayo-Wilson E, Mohr DC, Czajkowski SM, Thabane L, Collins LM, Rebok GW, Treweek SP, Cook TD, Edinger JD, Stoney CM, Campo RA, Young-Hyman D, Riley WT, National Institutes of Health Office of Behavioral and Social Sciences Research Expert Panel on Comparator Selection in Behavioral and Social Science Clinical Trials The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panel. J Clin Epidemiol. 2019 Jun;110:74–81. doi: 10.1016/j.jclinepi.2019.02.011.
    1. Lunde P, Nilsson BB, Bergland A, Kværner KJ, Bye A. The effectiveness of smartphone apps for lifestyle improvement in noncommunicable diseases: systematic review and meta-analyses. J Med Internet Res. 2018 May 04;20(5):e162. doi: 10.2196/jmir.9751.
    1. Bostock S, Crosswell AD, Prather AA, Steptoe A. Mindfulness on-the-go: effects of a mindfulness meditation app on work stress and well-being. J Occup Health Psychol. 2019 Feb;24(1):127–138. doi: 10.1037/ocp0000118.
    1. Champion L, Economides M, Chandler C. The efficacy of a brief app-based mindfulness intervention on psychosocial outcomes in healthy adults: a pilot randomised controlled trial. PLoS One. 2018;13(12):e0209482. doi: 10.1371/journal.pone.0209482.
    1. Economides M, Martman J, Bell MJ, Sanderson B. Improvements in stress, affect, and irritability following brief use of a mindfulness-based smartphone app: a randomized controlled trial. Mindfulness (N Y) 2018;9(5):1584–1593. doi: 10.1007/s12671-018-0905-4.
    1. Carissoli C, Villani D, Riva G. Does a meditation protocol supported by a mobile application help people reduce stress? Suggestions from a controlled pragmatic trial. Cyberpsychol Behav Soc Netw. 2015 Jan;18(1):46–53. doi: 10.1089/cyber.2014.0062.
    1. Huberty J, Green J, Glissmann C, Larkey L, Puzia M, Lee C. Efficacy of the mindfulness meditation mobile app "Calm" to reduce stress among college students: randomized controlled trial. JMIR Mhealth Uhealth. 2019 Jun 25;7(6):e14273. doi: 10.2196/14273.
    1. Huberty J, Eckert R, Larkey L, Kurka J, Rodríguez De Jesús SA, Yoo W, Mesa R. Smartphone-based meditation for myeloproliferative neoplasm patients: feasibility study to inform future trials. JMIR Form Res. 2019 Apr 29;3(2):e12662. doi: 10.2196/12662.
    1. Adams ZW, Sieverdes JC, Brunner-Jackson B, Mueller M, Chandler J, Diaz V, Patel S, Sox LR, Wilder S, Treiber FA. Meditation smartphone application effects on prehypertensive adults' blood pressure: dose-response feasibility trial. Health Psychol. 2018 Sep;37(9):850–860. doi: 10.1037/hea0000584.
    1. Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452–7. doi: 10.1016/j.amepre.2009.02.002.
    1. Huberty J, Eckert R, Gowin K, Mitchell J, Dueck AC, Ginos BF, Larkey L, Mesa R. Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms. Haematologica. 2017 Oct;102(10):e384–e388. doi: 10.3324/haematol.2017.168583.
    1. Cessna JM, Jim HSL, Sutton SK, Asvat Y, Small BJ, Salsman JM, Zachariah B, Fishman M, Field T, Fernandez H, Perez L, Jacobsen PB. Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients. J Psychosom Res. 2016 Feb;81:9–13. doi: 10.1016/j.jpsychores.2015.12.002.
    1. Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck CB, Bruner DW, Keefe FJ, Weinfurt KP. Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer. J Sex Med. 2013 Feb;10 Suppl 1:43–52. doi: 10.1111/j.1743-6109.2012.02995.x.
    1. Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009 Sep;18(7):873–80. doi: 10.1007/s11136-009-9496-9.
    1. Quach CW, Langer MM, Chen RC, Thissen D, Usinger DS, Emerson MA, Reeve BB. Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study. Qual Life Res. 2016 Nov;25(11):2811–2823. doi: 10.1007/s11136-016-1325-3.
    1. Scherber R, Dueck AC, Johansson P, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferarri ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Harrison CN, Radia D, Mesa RA. The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients. Blood. 2011 Jul 14;118(2):401–8. doi: 10.1182/blood-2011-01-328955.
    1. Bush NE, Smolenski DJ, Denneson LM, Williams HB, Thomas EK, Dobscha SK. A Virtual Hope Box: randomized controlled trial of a smartphone app for emotional regulation and coping with distress. Psychiatr Serv. 2017 Apr 01;68(4):330–336. doi: 10.1176/appi.ps.201600283.
    1. Goodwin K. Designing for the Digital Age: How to Create Human-Centered Products and Services. Hoboken, New Jersey: John Wiley & Sons; 2011.
    1. Liew MS, Zhang J, See J, Ong YL. Usability challenges for health and wellness mobile apps: mixed-methods study among mHealth experts and consumers. JMIR Mhealth Uhealth. 2019 Jan 30;7(1):e12160. doi: 10.2196/12160.
    1. Stawarz K, Preist C, Tallon D, Wiles N, Coyle D. User experience of cognitive behavioral therapy apps for depression: an analysis of app functionality and user reviews. J Med Internet Res. 2018 Jun 06;20(6):e10120. doi: 10.2196/10120.
    1. Di Sorbo AP, Alexandru C, Shimagaki J, Visaggio C, Canfora G, Gall H. What would users change in my app? Summarizing app reviews for recommending software changes. Proceedings of the 2016 24th ACM SIGSOFT International Symposium on Foundations of Software Engineering; 24th ACM SIGSOFT International Symposium on Foundations of Software Engineering; 2016; Seattle, Washington. 2016. pp. 499–510.
    1. Frie K, Hartmann-Boyce J, Jebb S, Albury C, Nourse R, Aveyard P. Insights from Google Play Store user reviews for the development of weight loss apps: mixed-method analysis. JMIR Mhealth Uhealth. 2017 Dec 22;5(12):e203. doi: 10.2196/mhealth.8791.

Source: PubMed

3
Abonner